NEW YORK, NY / ACCESS Newswire / November 3, 2025 / If you suffered a loss on your Tronox Holdings plc (NYSE:TROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/tronox-holdings-plc-lawsuit-submission-form?prid=175183&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

MGA's Miniverse(TM) Brings Minecraft(TM) to Life in Miniature with New Make It Mini(TM) Collection In Partnership with Minecraft, the Line Lets Fans Build, Craft, and Collect Iconic Minecraft Creations in the Real World GlobeNewswire November 03, 2025 MGA's Miniverse(TM) teams up with Minecraft for a new line of Minecraft(TM)-inspired miniature DIY collectibles. The MGA's Miniverse

Cipher Mining Provides Third Quarter 2025 Business Update GlobeNewswire November 03, 2025 Third Quarter 2025 Revenue of $72m and Non-GAAP Adjusted Earnings of $41m Executed 15-Year data center campus lease with Amazon Web Services to support AI workloads Secured Majority Ownership in Joint Venture to Develop 1-Gigawatt Site in West Texas NEW YORK, Nov. 03,

Quantum Corporation Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – QMCO GlobeNewswire November 03, 2025 LOS ANGELES, Nov. 03, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against Quantum Corporation (“Quantum” or “the Company”) (NASDAQ: QMCO) for violations of §§10(b)

Benitec Biopharma Provides Positive Interim Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial and Receives FDA Fast Track Designation for BB-301 GlobeNewswire November 03, 2025 Fast Track Designation was granted for BB-301 following FDA review of positive interim clinical study results and proprietary Responder Analysis planned for use in pivotal study for BB-301 BB-301

FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM GlobeNewswire November 03, 2025 Maranello (Italy), November 3, 2025 – Ferrari N.V. (NYSE/EXM: RACE) (“Ferrari” or the “Company“) informs that the Company has purchased, under the Euro 360 million share buyback program announced on July 31, 2025, as the eighth tranche of the multi-year share buyback program

NEW YORK CITY, NY / ACCESS Newswire / November 3, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against MoonLake Immunotherapeutics ("Moonlake" or the "Company") (NASDAQ:MLTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

uniQure Provides Regulatory Update on AMT-130 for Huntington's Disease GlobeNewswire November 03, 2025 LEXINGTON, Mass. and AMSTERDAM, Nov. 03, 2025 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that it received feedback from the U.S. Food and Drug Administration (FDA)

Kraig Biocraft Laboratories Confirms Spider Silk Production Operations Unaffected by Southeast Asia Typhoons due to Strategic Relocations to Highland Over Last 24 Months GlobeNewswire November 03, 2025 ANN ARBOR, Mich., Nov. 03, 2025 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), a world leader in spider silk technology*, today announced

Unicycive Therapeutics to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference GlobeNewswire November 03, 2025 LOS ALTOS, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today announced that Shalabh Gupta, M.D.,